AIMS/HYPOTHESIS: Several forkhead box (FOX) transcription factor family members have important roles in controlling pancreatic cell fates and maintaining beta cell mass and function, including FOXA1, FOXA2 and FOXM1. In this study we have examined the importance of FOXP1, FOXP2 and FOXP4 of the FOXP subfamily in islet cell development and function. METHODS: Mice harbouring floxed alleles for Foxp1, Foxp2 and Foxp4 were crossed with pan-endocrine Pax6-Cre transgenic mice to generate single and compound Foxp mutant mice. Mice were monitored for changes in glucose tolerance by IPGTT, serum insulin and glucagon levels by radioimmunoassay, and endocrine cell development and proliferation by immunohistochemistry. Gene expression and glucose-stimulated hormone secretion experiments were performed with isolated islets. RESULTS: Only the triple-compound Foxp1/2/4 conditional knockout (cKO) mutant had an overt islet phenotype, manifested physiologically by hypoglycaemia and hypoglucagonaemia. This resulted from the reduction in glucagon-secreting alpha cell mass and function. The proliferation of alpha cells was profoundly reduced in Foxp1/2/4 cKO islets through the effects on mediators of replication (i.e. decreased Ccna2, Ccnb1 and Ccnd2 activators, and increased Cdkn1a inhibitor). Adult islet Foxp1/2/4 cKO beta cells secrete insulin normally while the remaining alpha cells have impaired glucagon secretion. CONCLUSIONS/ INTERPRETATION: Collectively, these findings reveal an important role for the FOXP1, 2, and 4 proteins in governing postnatal alpha cell expansion and function.
AIMS/HYPOTHESIS: Several forkhead box (FOX) transcription factor family members have important roles in controlling pancreatic cell fates and maintaining beta cell mass and function, including FOXA1, FOXA2 and FOXM1. In this study we have examined the importance of FOXP1, FOXP2 and FOXP4 of the FOXP subfamily in islet cell development and function. METHODS: Mice harbouring floxed alleles for Foxp1, Foxp2 and Foxp4 were crossed with pan-endocrine Pax6-Cre transgenic mice to generate single and compound Foxp mutant mice. Mice were monitored for changes in glucose tolerance by IPGTT, serum insulin and glucagon levels by radioimmunoassay, and endocrine cell development and proliferation by immunohistochemistry. Gene expression and glucose-stimulated hormone secretion experiments were performed with isolated islets. RESULTS: Only the triple-compound Foxp1/2/4 conditional knockout (cKO) mutant had an overt islet phenotype, manifested physiologically by hypoglycaemia and hypoglucagonaemia. This resulted from the reduction in glucagon-secreting alpha cell mass and function. The proliferation of alpha cells was profoundly reduced in Foxp1/2/4 cKO islets through the effects on mediators of replication (i.e. decreased Ccna2, Ccnb1 and Ccnd2 activators, and increased Cdkn1a inhibitor). Adult islet Foxp1/2/4 cKO beta cells secrete insulin normally while the remaining alpha cells have impaired glucagon secretion. CONCLUSIONS/ INTERPRETATION: Collectively, these findings reveal an important role for the FOXP1, 2, and 4 proteins in governing postnatal alpha cell expansion and function.
Authors: Isabella Artner; John Le Lay; Yan Hang; Lynda Elghazi; Jonathan C Schisler; Eva Henderson; Beatriz Sosa-Pineda; Roland Stein Journal: Diabetes Date: 2006-02 Impact factor: 9.461
Authors: J E Liljenquist; G L Mueller; A D Cherrington; U Keller; J M Perry; W W Lacy; D Rabinowitz Journal: J Clin Invest Date: 1977-02 Impact factor: 14.808
Authors: E Danielle Dean; Mingyu Li; Nripesh Prasad; Scott N Wisniewski; Alison Von Deylen; Jason Spaeth; Lisette Maddison; Anthony Botros; Leslie R Sedgeman; Nadejda Bozadjieva; Olga Ilkayeva; Anastasia Coldren; Greg Poffenberger; Alena Shostak; Michael C Semich; Kristie I Aamodt; Neil Phillips; Hai Yan; Ernesto Bernal-Mizrachi; Jackie D Corbin; Kasey C Vickers; Shawn E Levy; Chunhua Dai; Christopher Newgard; Wei Gu; Roland Stein; Wenbiao Chen; Alvin C Powers Journal: Cell Metab Date: 2017-06-06 Impact factor: 27.287
Authors: Danny Ben-Zvi; Ornella Barrandon; Stephanie Hadley; Barak Blum; Quinn P Peterson; Douglas A Melton Journal: Proc Natl Acad Sci U S A Date: 2015-11-30 Impact factor: 11.205
Authors: Zeenat A Asghar; Andrew Cusumano; Zihan Yan; Maria S Remedi; Kelle H Moley Journal: Am J Physiol Endocrinol Metab Date: 2016-12-27 Impact factor: 4.310
Authors: Shane P Simonett; Sunyoung Shin; Jacob A Herring; Rhonda Bacher; Linsin A Smith; Chenyang Dong; Mary E Rabaglia; Donnie S Stapleton; Kathryn L Schueler; Jeea Choi; Matthew N Bernstein; Daniel R Turkewitz; Carlos Perez-Cervantes; Jason Spaeth; Roland Stein; Jeffery S Tessem; Christina Kendziorski; Sündüz Keleş; Ivan P Moskowitz; Mark P Keller; Alan D Attie Journal: J Clin Invest Date: 2021-11-01 Impact factor: 14.808
Authors: Chiara Lasconi; Matthew C Pahl; James A Pippin; Chun Su; Matthew E Johnson; Alessandra Chesi; Keith Boehm; Elisabetta Manduchi; Kristy Ou; Maria L Golson; Andrew D Wells; Klaus H Kaestner; Struan F A Grant Journal: Sleep Date: 2022-08-11 Impact factor: 6.313
Authors: Shanru Li; Michael Morley; MinMin Lu; Su Zhou; Kathleen Stewart; Catherine A French; Haley O Tucker; Simon E Fisher; Edward E Morrisey Journal: Dev Biol Date: 2016-06-21 Impact factor: 3.582
Authors: Wu-Lin Charng; Ender Karaca; Zeynep Coban Akdemir; Tomasz Gambin; Mehmed M Atik; Shen Gu; Jennifer E Posey; Shalini N Jhangiani; Donna M Muzny; Harsha Doddapaneni; Jianhong Hu; Eric Boerwinkle; Richard A Gibbs; Jill A Rosenfeld; Hong Cui; Fan Xia; Kandamurugu Manickam; Yaping Yang; Eissa A Faqeih; Ali Al Asmari; Mohammed A M Saleh; Ayman W El-Hattab; James R Lupski Journal: BMC Med Genomics Date: 2016-07-19 Impact factor: 3.063